Abstract:Background: Acute kidney injury (AKI) is one of the most important causes of mortality and morbidity worldwide. Mesenchymal stem cells (MSCs) can be used for stem cell-based therapy containing AKI. Magnetic resonance imaging (MRI) is an ideal mean for stem cells tracking by labeling with superparamagnetic iron oxide (SPIO). Therefore, using the iron oxide-labeled mesenchymal stem cells (MSC) to treat the AKI and evaluating migration, distribution, and homing of cells by MRI is an ideal method for cell therapy and cell tracking in vivo. Methods: In vitro, the MSCs were labeled with 25 μg/mL for 24 h, and test the labeled efficiency and cells viability. In vitro experiments, magnetic resonance imaging (MRI) measurement of non-labeled and SPIO-labeled MSCs (SPIO-MSCs) was performed in correlation to detectable cells concentrations and detectable time windows. In vivo experiments, MRI evaluation was performed before and after ischemic/reperfusion AKI (N = 14) and intravenous injection of 5 × 10(5) SPIO-MSCs (N = 10), PBS (N = 6) up to 8 days using a clinical 1.5 T scanner. Signal intensity of kidneys were measured and tested for statistical significance (unpaired Student's t-test, p < 0.05) in comparison histology (hematoxylin and eosin [H&E], Prussian blue). Results: In vitro, MSCs can be labeled with the SPIO without affecting the viability and labeling efficiency. SPIO-MSCs showed a reduction of signal intensity at T2WI and T2*WI, 5 × 10(4) cells/mL, SPIO-MSCs were the minimum imaging cells concentration using a 1.5 T MR in vitro. In vivo, SPIO-MSCs administration resulted in a T2*WI signal intensity decrease in renal medulla caused by SPIO-MSCs accumulation in contrast to control groups (p < 0.05) up to day 3 after transplantation, but T2*WI low signal intensity region of the renal medulla revealed an decrease at day 5, and no significant differences between SPIO-MSCs and control animals at day 8. Conclusion: Our data demonstrate that in vitro and in vivo, cell-tracking and monitoring of kidney distribution of intravenous injected SPIO-MSCs after AKI is feasible in MRI at 1.5 T.

Optimal technique for canine mesenchymal stem cells labeling with novel SPIO, MIRBTM: for MRI detection of transplanted stem cells canine stroke model

Labeling Neural Stem Cells with Superparamagnetic Iron Oxide and MRI Tracking in Vitro and in Vivo

The Application of Super Paramagnetic Iron Oxide-Labeled Mesenchymal Stem Cells in Cell-Based Therapy

Stem Cell Labeling With Superparamagnetic Iron Oxide Nanoparticles Using Focused Ultrasound And Magnetic Resonance Imaging Tracking

In Vivo MR Imaging of Intraarterially Delivered Magnetically Labeled Mesenchymal Stem Cells in a Canine Stroke Model

MRI tracking study of SPIO labeled bone marrow stromal cells transplantation for treatment of lacunar stroke

Tracking mesenchymal stem cells using magnetic resonance imaging

Study on Magnetic Resonance Imaging of SPIO Labeled Bone Marrow Stem Cells in Parkinson’s Rat Model Following Transplantation

Magnetic Resonance Tracking of Transplanted Neural Stem Cells Labeled with Superparamagnetic Iron Oxides in APP/PS1 Transgenic Mice

Labeling of Cynomolgus Monkey Bone Marrow-Derived Mesenchymal Stem Cells for Cell Tracking by Multimodality Imaging.

Superparamagnetic Iron Oxide Nanoparticles-Complexed Cationic Amylose for In Vivo Magnetic Resonance Imaging Tracking of Transplanted Stem Cells in Stroke

In vivo magnetic resonance imaging of iron oxide-labeled, intravenous-injected mesenchymal stem cells in kidneys of rabbits with acute ischemic kidney injury: detection and monitoring at 1.5 T

Labeling mesenchymal stem cells in the heart with superparamagnetic iron oxide nanoparticles in vitro and tracking after implantation with MRI in vivo

Superparamagnetic Iron Oxide-Loaded Cationic Polymersomes for Cellular Mr Imaging of Therapeutic Stem Cells in Stroke

The SPIO Labeling of Mature Dogs BMSCs in Vitro

Study of SPIO Labeled or BrdU Labeled Bone Marrow Mesenchymal Stem Cells in Parkinson's Rat Model Following Transplantation

In Vivo Cardiac Magnetic Resonance Imaging of Superparamagnetic Iron Oxides-Labeled Mesenchymal Stem Cells in Swines

Differentiation of Genetically Modified Canine Bone Mesenchymal Stem Cells Labeled with Superparamagnetic Iron Oxide into Neural‑like Cells.

Low molecular weight alkyl-polycation wrapped magnetite nanoparticle clusters as MRI probes for stem cell labeling and in vivo imaging.

[Osteogenic and Tracking Study of Bone Marrow Stromal Stem Cells in Vivo].

In Vivo Labeling of Rat Neural Progenitor Cells in Subventricular Zone with Superparamagnetic Iron Oxide for Tracking of Magnetic Resonance Imaging